spacer
home > pmps
PUBLICATIONS

Pharmaceutical Manufacturing and Packing Sourcer

 

Pharmaceutical Manufacturing and Packing Sourcer (PMPS) is a specialist journal designed to provide worldwide coverage of a range of topics relating to the pharmaceutical manufacturing and packaging sector.

Published quarterly, the journal functions as a platform of communication and information-sharing for executive and strategic decision makers within the industry, identifying new
trends and marketing opportunities, as well as highlighting the latest innovations in this
dynamic environment. PMPS is specifically designed to interest those in the pharma, biotech, nutritional, and medical device industries who are actively seeking to source services for improved efficiency in what is an increasingly competitive market.




 
For further information please contact:

Advertising
Nicholas Matthews

Editorial
Jasmine Callaghan

We're also on Twitter! Follow us @PMPSmag  

Read our publications on the go in the Samedan app for phones and tablets. You can download issues for offline reading, and our archives go as far back as 2008! Download for free on the App Store, GooglePlay, or Amazon.

     


Click here to view the digital version of PMPS

 


  Click here to view the digital version of PMPS's Parenteral Technology Supplement
 

pmps
 
 
Featured in this issue
Feature topics
Q&A: Encapsulation Technology

Recent Developments

PMPS spoke to Fernando Diez at ACG to get the latest on recent progression made across encapsulation technology, particularly hard capsule manufacturing.
innovative packaging
Mitigating Risk in Global Transportation

Cold Chain Compliance

Adam Tetz at Pelican BioThermal explores the ever-changing world of temperaturecontrolled packaging and discusses the latest developments in global transportation.
  Improving Adherence
The Placebo Effect in Manufacturing

Unseen Ailments

Maintaining a strong and reputable position in one of the most competitive industries is essential for business. Aptean’s James Wood discusses how end-consumers can be protected through optimised manufacturing procedures.

spacer
Edited by
Randice Altschul
Chief Executive Officer at Pop Test and Palisades Therapeutics

Published quarterly in
February, May,
August, and November


Widgets Magazine
 

Widgets Magazine
Industry Events

LogiPharma 2019

9-11 April 2019, Montreux Music & Convention Centre

LogiPharma is the world’s leading pharma supply chain event. With over 950+ pharma supply chain leaders exclusively meeting in one place at one time, LogiPharma is THE meeting place to benchmark your business with the best pharma companies and shape the future of your industry.
More info >>

 
News and Press Releases

Datwyler celebrates official opening of its new production plant with First Line standard in Middletown, Del

• The new facility in Middletown, Del., is Datwyler’s third facility with First Line standard which will be catering to the markets in North and South America • Approximately 120 jobs will be created, with the majority staffed from the local community • With the Middletown facility, Datwyler will be able to increase its global First Line production by 50 percent by 2020 • First Line is specially designed to manufacture biotech and pharmaceutical elastomer components in a fully integrated good manufacturing practice (GMP) environment
More info >>

air transport logo

 

White Papers

Extractables and Leachables Testing: A Risk Based Approach

RSSL

Pharmaceutical products are in contact with many external components during both manufacture and usage and small amounts of chemicals may leach from these components with a potential health risk to the patient. Extractables and leachables (E&L) studies therefore play an important role in verifying the safety of a drug product over its lifetime. Regulatory organisations such as the US Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) are taking an increased interest in the interactions of various drug delivery devices, pharmaceutical product containers and medical devices with drug product and/or patient and this field is therefore growing in importance. Regulatory guidelines indicate that an extractables profile should be determined for all materials that contact the drug product. Once established, this profile can be used to determine whether any of these extractables are present as leachables within the product. If a leachable is detected, amounts can be determined using validated analytical methods, after which a biological risk can be established based on the exposure. This white paper will provide an overview of the processes used to determine extractables and leachables from plastics.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement